151 related articles for article (PubMed ID: 14618257)
1. Implication of phosphoinositide phosphatases in genetic diseases: the case of myotubularin.
Tronchère H; Buj-Bello A; Mandel JL; Payrastre B
Cell Mol Life Sci; 2003 Oct; 60(10):2084-99. PubMed ID: 14618257
[TBL] [Abstract][Full Text] [Related]
2. The myotubularin family: from genetic disease to phosphoinositide metabolism.
Laporte J; Blondeau F; Buj-Bello A; Mandel JL
Trends Genet; 2001 Apr; 17(4):221-8. PubMed ID: 11275328
[TBL] [Abstract][Full Text] [Related]
3. The myotubularin family: novel phosphoinositide regulators.
Nandurkar HH; Huysmans R
IUBMB Life; 2002 Jan; 53(1):37-43. PubMed ID: 12018406
[TBL] [Abstract][Full Text] [Related]
4. The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles.
Laporte J; Blondeau F; Gansmuller A; Lutz Y; Vonesch JL; Mandel JL
J Cell Sci; 2002 Aug; 115(Pt 15):3105-17. PubMed ID: 12118066
[TBL] [Abstract][Full Text] [Related]
5. The structure and regulation of myotubularin phosphatases.
Begley MJ; Dixon JE
Curr Opin Struct Biol; 2005 Dec; 15(6):614-20. PubMed ID: 16289848
[TBL] [Abstract][Full Text] [Related]
6. Myotubularin phosphatases: policing 3-phosphoinositides.
Robinson FL; Dixon JE
Trends Cell Biol; 2006 Aug; 16(8):403-12. PubMed ID: 16828287
[TBL] [Abstract][Full Text] [Related]
7. Myotubularin phosphoinositide phosphatases in human diseases.
Amoasii L; Hnia K; Laporte J
Curr Top Microbiol Immunol; 2012; 362():209-33. PubMed ID: 23086420
[TBL] [Abstract][Full Text] [Related]
8. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport.
Chaussade C; Pirola L; Bonnafous S; Blondeau F; Brenz-Verca S; Tronchère H; Portis F; Rusconi S; Payrastre B; Laporte J; Van Obberghen E
Mol Endocrinol; 2003 Dec; 17(12):2448-60. PubMed ID: 14500759
[TBL] [Abstract][Full Text] [Related]
9. Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells.
Tronchère H; Laporte J; Pendaries C; Chaussade C; Liaubet L; Pirola L; Mandel JL; Payrastre B
J Biol Chem; 2004 Feb; 279(8):7304-12. PubMed ID: 14660569
[TBL] [Abstract][Full Text] [Related]
10. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
Kim SA; Taylor GS; Torgersen KM; Dixon JE
J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541
[TBL] [Abstract][Full Text] [Related]
11. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
[TBL] [Abstract][Full Text] [Related]
12. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.
Tosch V; Rohde HM; Tronchère H; Zanoteli E; Monroy N; Kretz C; Dondaine N; Payrastre B; Mandel JL; Laporte J
Hum Mol Genet; 2006 Nov; 15(21):3098-106. PubMed ID: 17008356
[TBL] [Abstract][Full Text] [Related]
13. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of X-linked myotubular myopathy by detection of myotubularin.
Laporte J; Kress W; Mandel JL
Ann Neurol; 2001 Jul; 50(1):42-6. PubMed ID: 11456308
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.
Begley MJ; Taylor GS; Kim SA; Veine DM; Dixon JE; Stuckey JA
Mol Cell; 2003 Dec; 12(6):1391-402. PubMed ID: 14690594
[TBL] [Abstract][Full Text] [Related]
16. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
[TBL] [Abstract][Full Text] [Related]
17. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.
Taylor GS; Maehama T; Dixon JE
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8910-5. PubMed ID: 10900271
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.
Kutchukian C; Lo Scrudato M; Tourneur Y; Poulard K; Vignaud A; Berthier C; Allard B; Lawlor MW; Buj-Bello A; Jacquemond V
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14432-14437. PubMed ID: 27911767
[TBL] [Abstract][Full Text] [Related]
19. Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction.
Tsujita K; Itoh T; Ijuin T; Yamamoto A; Shisheva A; Laporte J; Takenawa T
J Biol Chem; 2004 Apr; 279(14):13817-24. PubMed ID: 14722070
[TBL] [Abstract][Full Text] [Related]
20. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
